Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Jung

Showing results (91-100 of 253) with videos related to

Pageof 26
Sort By:
Chemical Record (New York, N.Y.)|June 23, 2018
Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2 - New Opportunities, New QuestionsDina Robaa, Daria Monaldi, Nathalie Wössner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 30, 2020
Syntheses of Thailandepsin B Pseudo-Natural Products: Access to New Highly Potent HDAC Inhibitors via Late-Stage ModificationJana Brosowsky, Monika Lutterbeck, Amelie Liebich, et al.
Anti-Cancer Drugs|June 3, 2005
Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell linesSybille Wittich, Hans Scherf, Changping Xie, et al.
Experimental Hematology|March 20, 2003
Hydroxamide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expressionEvangelia Skarpidi, Hua Cao, Birgit Heltweg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Diminished sensitivity of chronic lymphocytic leukemia cells to ABT-737 and ABT-263 due to albumin binding in bloodMeike Vogler, Silviya D Furdas, Manfred Jung, et al.
Journal of Chemical Information and Modeling|January 1, 2014
Virtual screening of PRK1 inhibitors: ensemble docking, rescoring using binding free energy calculation and QSAR model developmentInna Slynko, Michael Scharfe, Tobias Rumpf, et al.
Journal of Medicinal Chemistry|May 20, 2025
Efficient Crystallization of Apo Sirt2 for Small-Molecule Soaking and Structural Analysis of Ligand InteractionsFlorian Friedrich, Matthias Schiedel, Sören Swyter, et al.
Journal of Medicinal Chemistry|February 14, 2008
Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding modeRobert C Neugebauer, Urszula Uchiechowska, Rene Meier, et al.
International Journal of Molecular Sciences|August 28, 2020
Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic PathwaysLars Kaiser, Helga Weinschrott, Isabel Quint, et al.
Bioorganic & Medicinal Chemistry|February 15, 2011
Synthesis and biological activity of splitomicin analogs targeted at human NAD(+)-dependent histone deacetylases (sirtuins)Marcus Freitag, Jörg Schemies, Tim Larsen, et al.
Pageof 26

Showing results (91-100 of 253) with videos related to

Sort By:
Pageof 26
Chemical Record (New York, N.Y.)|June 23, 2018
Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2 - New Opportunities, New QuestionsDina Robaa, Daria Monaldi, Nathalie Wössner, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 30, 2020
Syntheses of Thailandepsin B Pseudo-Natural Products: Access to New Highly Potent HDAC Inhibitors via Late-Stage ModificationJana Brosowsky, Monika Lutterbeck, Amelie Liebich, et al.
Anti-Cancer Drugs|June 3, 2005
Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell linesSybille Wittich, Hans Scherf, Changping Xie, et al.
Experimental Hematology|March 20, 2003
Hydroxamide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expressionEvangelia Skarpidi, Hua Cao, Birgit Heltweg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Diminished sensitivity of chronic lymphocytic leukemia cells to ABT-737 and ABT-263 due to albumin binding in bloodMeike Vogler, Silviya D Furdas, Manfred Jung, et al.
Journal of Chemical Information and Modeling|January 1, 2014
Virtual screening of PRK1 inhibitors: ensemble docking, rescoring using binding free energy calculation and QSAR model developmentInna Slynko, Michael Scharfe, Tobias Rumpf, et al.
Journal of Medicinal Chemistry|May 20, 2025
Efficient Crystallization of Apo Sirt2 for Small-Molecule Soaking and Structural Analysis of Ligand InteractionsFlorian Friedrich, Matthias Schiedel, Sören Swyter, et al.
Journal of Medicinal Chemistry|February 14, 2008
Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding modeRobert C Neugebauer, Urszula Uchiechowska, Rene Meier, et al.
International Journal of Molecular Sciences|August 28, 2020
Metabolite Patterns in Human Myeloid Hematopoiesis Result from Lineage-Dependent Active Metabolic PathwaysLars Kaiser, Helga Weinschrott, Isabel Quint, et al.
Bioorganic & Medicinal Chemistry|February 15, 2011
Synthesis and biological activity of splitomicin analogs targeted at human NAD(+)-dependent histone deacetylases (sirtuins)Marcus Freitag, Jörg Schemies, Tim Larsen, et al.
Pageof 26